Archive for the ‘Asthma and Chronic Airflow Limitation’ Category - Part 4

Intravenously administered aminophylline still is widely used, usually together with inhaled, or less commonly, systemically administered adrenoceptor agonists, in the initial treatment of patients presenting to the emergency room with an acute exacerbation of asthma — buy asthma inhaler. In this setting, is the use of aminophylline beneficial or necessary? This question was subjected to […]

Methylxanthines have, for almost 50 years, been regarded as first-line therapy in the management of airflow obstruction due to asthma and bronchitis in adults and children. In recent years, however, the therapeutic emphasis has shifted from simply managing the bronchoconstriction associated with these conditions, to treating the underlying inflammation, thus preventing bronchospasm. At the same […]